More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$1.63B
EPS
0.96
P/E ratio
42.1
Price to sales
1.31
Dividend yield
--
Beta
0.887223
Previous close
$35.03
Today's open
$34.88
Day's range
$34.45 - $35.56
52 week range
$31.75 - $55
show more
CEO
Randall A. Lipps
Employees
3580
Headquarters
Fort Worth, TX
Exchange
Nasdaq Global Select
Shares outstanding
45995034
Issue type
Common Stock
Healthcare
Healthcare Providers & Services
Beat Value Traps: 4 Stocks With Attractive PEG Ratios to Buy Now
Discover four stocks with attractive PEG ratios, strong earnings growth prospects and favorable value scores that could help investors avoid value traps.
Zacks Investment Research • Nov 13, 2026

4 Undervalued Stocks That Could Benefit from a Wall Street Rally
Wall Street's rally puts undervalued stocks in focus. AVT, OMCL, HPE and LCUT stand out for attractive valuations, earnings growth prospects and upside potential.
Zacks Investment Research • Nov 10, 2026

Buy These 3 Stocks with Broker Rating Upgrades for Big Gains
Cinemark Holdings, Diamondback Energy and Omnicell stand out with recent broker rating upgrades and strong projected earnings growth for 2026.
Zacks Investment Research • Nov 10, 2026

Why Omnicell (OMCL) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks Investment Research • Nov 9, 2026

Does Omnicell (OMCL) Have the Potential to Rally 40.83% as Wall Street Analysts Expect?
The consensus price target hints at a 40.8% upside potential for Omnicell (OMCL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Zacks Investment Research • Nov 5, 2026

Why Omnicell (OMCL) Might be Well Poised for a Surge
Omnicell (OMCL) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Zacks Investment Research • Nov 5, 2026

New Strong Buy Stocks for November 5th
HTO, SWKS, OMCL, CR and EXPD have been added to the Zacks Rank #1 (Strong Buy) List on November 5, 2026.
Zacks Investment Research • Nov 5, 2026

Top Robotics Stocks With Strong Potential for Long-Term Growth
Robotics is poised for robust long-term growth. Consider OMCL, SNPS, CDNS and MCHP for potential market dominance across sectors.
Zacks Investment Research • Nov 5, 2026

OMCL vs. VEEV: Which Stock Should Value Investors Buy Now?
Investors with an interest in Medical Info Systems stocks have likely encountered both Omnicell (OMCL) and Veeva Systems (VEEV). But which of these two companies is the best option for those looking for undervalued stocks?
Zacks Investment Research • Nov 5, 2026

Best Momentum Stocks to Buy for November 5th
HTO, CR and OMCL made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on November 5, 2026.
Zacks Investment Research • Nov 5, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Omnicell Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.